Table of Content

1 Hepatic Encephalopathy Drug Market Overview
1.1 Hepatic Encephalopathy Drug Product Scope
1.2 Hepatic Encephalopathy Drug Segment by Type
1.2.1 Global Hepatic Encephalopathy Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 RBX-2660
1.2.3 KLS-13019
1.2.4 GR-3027
1.2.5 SYNB-1020
1.2.6 Others
1.3 Hepatic Encephalopathy Drug Segment by Application
1.3.1 Global Hepatic Encephalopathy Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Hepatic Encephalopathy Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hepatic Encephalopathy Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hepatic Encephalopathy Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hepatic Encephalopathy Drug Price Trends (2016-2027)

2 Hepatic Encephalopathy Drug Estimates and Forecasts by Region
2.1 Global Hepatic Encephalopathy Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hepatic Encephalopathy Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hepatic Encephalopathy Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Hepatic Encephalopathy Drug Revenue Market Share by Region (2016-2021)
2.3 Global Hepatic Encephalopathy Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hepatic Encephalopathy Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hepatic Encephalopathy Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)
2.4.2 Europe Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)
2.4.3 China Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)
2.4.4 Japan Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)
2.4.6 India Hepatic Encephalopathy Drug Estimates and Projections (2016-2027)

3 Global Hepatic Encephalopathy Drug Competition Landscape by Players
3.1 Global Top Hepatic Encephalopathy Drug Players by Sales (2016-2021)
3.2 Global Top Hepatic Encephalopathy Drug Players by Revenue (2016-2021)
3.3 Global Hepatic Encephalopathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Drug as of 2020)
3.4 Global Hepatic Encephalopathy Drug Average Price by Company (2016-2021)
3.5 Manufacturers Hepatic Encephalopathy Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Hepatic Encephalopathy Drug Market Size by Type
4.1 Global Hepatic Encephalopathy Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Hepatic Encephalopathy Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Hepatic Encephalopathy Drug Price by Type (2016-2021)
4.2 Global Hepatic Encephalopathy Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hepatic Encephalopathy Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatic Encephalopathy Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Hepatic Encephalopathy Drug Price Forecast by Type (2022-2027)

5 Global Hepatic Encephalopathy Drug Market Size by Application
5.1 Global Hepatic Encephalopathy Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Hepatic Encephalopathy Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Hepatic Encephalopathy Drug Price by Application (2016-2021)
5.2 Global Hepatic Encephalopathy Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hepatic Encephalopathy Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatic Encephalopathy Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatic Encephalopathy Drug Price Forecast by Application (2022-2027)

6 North America Hepatic Encephalopathy Drug Market Facts & Figures
6.1 North America Hepatic Encephalopathy Drug Sales by Company
6.1.1 North America Hepatic Encephalopathy Drug Sales by Company (2016-2021)
6.1.2 North America Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
6.2 North America Hepatic Encephalopathy Drug Sales Breakdown by Type
6.2.1 North America Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
6.3 North America Hepatic Encephalopathy Drug Sales Breakdown by Application
6.3.1 North America Hepatic Encephalopathy Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Hepatic Encephalopathy Drug Sales Breakdown by Application (2022-2027)

7 Europe Hepatic Encephalopathy Drug Market Facts & Figures
7.1 Europe Hepatic Encephalopathy Drug Sales by Company
7.1.1 Europe Hepatic Encephalopathy Drug Sales by Company (2016-2021)
7.1.2 Europe Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
7.2 Europe Hepatic Encephalopathy Drug Sales Breakdown by Type
7.2.1 Europe Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Hepatic Encephalopathy Drug Sales Breakdown by Application
7.3.1 Europe 119 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 119 Sales Breakdown by Application (2022-2027)

8 China Hepatic Encephalopathy Drug Market Facts & Figures
8.1 China Hepatic Encephalopathy Drug Sales by Company
8.1.1 China Hepatic Encephalopathy Drug Sales by Company (2016-2021)
8.1.2 China Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
8.2 China Hepatic Encephalopathy Drug Sales Breakdown by Type
8.2.1 China Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
8.3 China Hepatic Encephalopathy Drug Sales Breakdown by Application
8.3.1 China 144 Sales Breakdown by Application (2016-2021)
8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Hepatic Encephalopathy Drug Market Facts & Figures
9.1 Japan Hepatic Encephalopathy Drug Sales by Company
9.1.1 Japan Hepatic Encephalopathy Drug Sales by Company (2016-2021)
9.1.2 Japan Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
9.2 Japan Hepatic Encephalopathy Drug Sales Breakdown by Type
9.2.1 Japan Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Hepatic Encephalopathy Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hepatic Encephalopathy Drug Market Facts & Figures
10.1 Southeast Asia Hepatic Encephalopathy Drug Sales by Company
10.1.1 Southeast Asia Hepatic Encephalopathy Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Hepatic Encephalopathy Drug Sales Breakdown by Type
10.2.1 Southeast Asia Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hepatic Encephalopathy Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Hepatic Encephalopathy Drug Market Facts & Figures
11.1 India Hepatic Encephalopathy Drug Sales by Company
11.1.1 India Hepatic Encephalopathy Drug Sales by Company (2016-2021)
11.1.2 India Hepatic Encephalopathy Drug Revenue by Company (2016-2021)
11.2 India Hepatic Encephalopathy Drug Sales Breakdown by Type
11.2.1 India Hepatic Encephalopathy Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Hepatic Encephalopathy Drug Sales Breakdown by Type (2022-2027)
11.3 India Hepatic Encephalopathy Drug Sales Breakdown by Application
11.3.1 India Hepatic Encephalopathy Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Hepatic Encephalopathy Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hepatic Encephalopathy Drug Business
12.1 Alfa Wassermann S.p.A
12.1.1 Alfa Wassermann S.p.A Corporation Information
12.1.2 Alfa Wassermann S.p.A Business Overview
12.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Products Offered
12.1.5 Alfa Wassermann S.p.A Recent Development
12.2 Cosmo Pharmaceuticals S.p.A
12.2.1 Cosmo Pharmaceuticals S.p.A Corporation Information
12.2.2 Cosmo Pharmaceuticals S.p.A Business Overview
12.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Products Offered
12.2.5 Cosmo Pharmaceuticals S.p.A Recent Development
12.3 Horizon Pharma Plc
12.3.1 Horizon Pharma Plc Corporation Information
12.3.2 Horizon Pharma Plc Business Overview
12.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Horizon Pharma Plc Hepatic Encephalopathy Drug Products Offered
12.3.5 Horizon Pharma Plc Recent Development
12.4 KannaLife Sciences, Inc.
12.4.1 KannaLife Sciences, Inc. Corporation Information
12.4.2 KannaLife Sciences, Inc. Business Overview
12.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Products Offered
12.4.5 KannaLife Sciences, Inc. Recent Development
12.5 Ocera Therapeutics, Inc.
12.5.1 Ocera Therapeutics, Inc. Corporation Information
12.5.2 Ocera Therapeutics, Inc. Business Overview
12.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Products Offered
12.5.5 Ocera Therapeutics, Inc. Recent Development
12.6 Rebiotix Inc.
12.6.1 Rebiotix Inc. Corporation Information
12.6.2 Rebiotix Inc. Business Overview
12.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Rebiotix Inc. Hepatic Encephalopathy Drug Products Offered
12.6.5 Rebiotix Inc. Recent Development
12.7 Spherium Biomed S.L.
12.7.1 Spherium Biomed S.L. Corporation Information
12.7.2 Spherium Biomed S.L. Business Overview
12.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Spherium Biomed S.L. Hepatic Encephalopathy Drug Products Offered
12.7.5 Spherium Biomed S.L. Recent Development
12.8 Umecrine Cognition AB
12.8.1 Umecrine Cognition AB Corporation Information
12.8.2 Umecrine Cognition AB Business Overview
12.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Umecrine Cognition AB Hepatic Encephalopathy Drug Products Offered
12.8.5 Umecrine Cognition AB Recent Development

13 Hepatic Encephalopathy Drug Manufacturing Cost Analysis
13.1 Hepatic Encephalopathy Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug
13.4 Hepatic Encephalopathy Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatic Encephalopathy Drug Distributors List
14.3 Hepatic Encephalopathy Drug Customers

15 Market Dynamics
15.1 Hepatic Encephalopathy Drug Market Trends
15.2 Hepatic Encephalopathy Drug Drivers
15.3 Hepatic Encephalopathy Drug Market Challenges
15.4 Hepatic Encephalopathy Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hepatic Encephalopathy Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hepatic Encephalopathy Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hepatic Encephalopathy Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Hepatic Encephalopathy Drug Sales Market Share by Region (2016-2021)
Table 6. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hepatic Encephalopathy Drug Revenue Share by Region (2016-2021)
Table 8. Global Hepatic Encephalopathy Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Hepatic Encephalopathy Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hepatic Encephalopathy Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hepatic Encephalopathy Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Hepatic Encephalopathy Drug Sales Share by Company (2016-2021)
Table 14. Global Hepatic Encephalopathy Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hepatic Encephalopathy Drug Revenue Share by Company (2016-2021)
Table 16. Global Hepatic Encephalopathy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatic Encephalopathy Drug as of 2020)
Table 17. Global Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Hepatic Encephalopathy Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Hepatic Encephalopathy Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Hepatic Encephalopathy Drug Sales Share by Type (2016-2021)
Table 23. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Hepatic Encephalopathy Drug Sales Share by Type (2022-2027)
Table 26. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hepatic Encephalopathy Drug Revenue Share by Type (2022-2027)
Table 28. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Hepatic Encephalopathy Drug Sales Share by Application (2016-2021)
Table 31. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Hepatic Encephalopathy Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Hepatic Encephalopathy Drug Sales Share by Application (2022-2027)
Table 35. Global Hepatic Encephalopathy Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hepatic Encephalopathy Drug Revenue Share by Application (2022-2027)
Table 37. Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 40. North America Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 44. North America Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 46. North America Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 48. North America Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 62. China Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 64. China Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 66. China Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 68. China Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 70. China Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 72. China Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 98. India Hepatic Encephalopathy Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Hepatic Encephalopathy Drug Sales Market Share by Company (2016-2021)
Table 100. India Hepatic Encephalopathy Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hepatic Encephalopathy Drug Revenue Market Share by Company (2016-2021)
Table 102. India Hepatic Encephalopathy Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Hepatic Encephalopathy Drug Sales Market Share by Type (2016-2021)
Table 104. India Hepatic Encephalopathy Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Hepatic Encephalopathy Drug Sales Market Share by Type (2022-2027)
Table 106. India Hepatic Encephalopathy Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Hepatic Encephalopathy Drug Sales Market Share by Application (2016-2021)
Table 108. India Hepatic Encephalopathy Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Hepatic Encephalopathy Drug Sales Market Share by Application (2022-2027)
Table 110. Alfa Wassermann S.p.A Corporation Information
Table 111. Alfa Wassermann S.p.A Description and Business Overview
Table 112. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product
Table 114. Alfa Wassermann S.p.A Recent Development
Table 115. Cosmo Pharmaceuticals S.p.A Corporation Information
Table 116. Cosmo Pharmaceuticals S.p.A Description and Business Overview
Table 117. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product
Table 119. Cosmo Pharmaceuticals S.p.A Recent Development
Table 120. Horizon Pharma Plc Corporation Information
Table 121. Horizon Pharma Plc Description and Business Overview
Table 122. Horizon Pharma Plc Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Horizon Pharma Plc Hepatic Encephalopathy Drug Product
Table 124. Horizon Pharma Plc Recent Development
Table 125. KannaLife Sciences, Inc. Corporation Information
Table 126. KannaLife Sciences, Inc. Description and Business Overview
Table 127. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product
Table 129. KannaLife Sciences, Inc. Recent Development
Table 130. Ocera Therapeutics, Inc. Corporation Information
Table 131. Ocera Therapeutics, Inc. Description and Business Overview
Table 132. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product
Table 134. Ocera Therapeutics, Inc. Recent Development
Table 135. Rebiotix Inc. Corporation Information
Table 136. Rebiotix Inc. Description and Business Overview
Table 137. Rebiotix Inc. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Rebiotix Inc. Hepatic Encephalopathy Drug Product
Table 139. Rebiotix Inc. Recent Development
Table 140. Spherium Biomed S.L. Corporation Information
Table 141. Spherium Biomed S.L. Description and Business Overview
Table 142. Spherium Biomed S.L. Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Spherium Biomed S.L. Hepatic Encephalopathy Drug Product
Table 144. Spherium Biomed S.L. Recent Development
Table 145. Umecrine Cognition AB Corporation Information
Table 146. Umecrine Cognition AB Hepatic Encephalopathy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Umecrine Cognition AB Description and Business Overview
Table 148. Umecrine Cognition AB Hepatic Encephalopathy Drug Product
Table 149. Umecrine Cognition AB Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Hepatic Encephalopathy Drug Distributors List
Table 153. Hepatic Encephalopathy Drug Customers List
Table 154. Hepatic Encephalopathy Drug Market Trends
Table 155. Hepatic Encephalopathy Drug Market Drivers
Table 156. Hepatic Encephalopathy Drug Market Challenges
Table 157. Hepatic Encephalopathy Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatic Encephalopathy Drug Product Picture
Figure 2. Global Hepatic Encephalopathy Drug Sales Market Share by Type in 2021 & 2027
Figure 3. RBX-2660 Product Picture
Figure 4. KLS-13019 Product Picture
Figure 5. GR-3027 Product Picture
Figure 6. SYNB-1020 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hepatic Encephalopathy Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Hepatic Encephalopathy Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hepatic Encephalopathy Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Hepatic Encephalopathy Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Hepatic Encephalopathy Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Hepatic Encephalopathy Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Hepatic Encephalopathy Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Hepatic Encephalopathy Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Hepatic Encephalopathy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Hepatic Encephalopathy Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Hepatic Encephalopathy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Hepatic Encephalopathy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Hepatic Encephalopathy Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Hepatic Encephalopathy Drug Players Market Share by Revenue in Hepatic Encephalopathy Drug: 2016 & 2020
Figure 31. Hepatic Encephalopathy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Hepatic Encephalopathy Drug Revenue Share by Type (2016-2021)
Figure 33. Global Hepatic Encephalopathy Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Hepatic Encephalopathy Drug Revenue Share by Application (2016-2021)
Figure 35. Global Hepatic Encephalopathy Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 37. North America Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 38. Europe Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 39. Europe Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 40. China Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 41. China Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 42. Japan Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 43. Japan Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 46. India Hepatic Encephalopathy Drug Sales Market Share by Type in 2020
Figure 47. India Hepatic Encephalopathy Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Hepatic Encephalopathy Drug
Figure 50. Manufacturing Process Analysis of Hepatic Encephalopathy Drug
Figure 51. Hepatic Encephalopathy Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed